BlackfinBio is a spinout company from the University of Sheffield, leveraging the university’s research and intellectual property to pursue its innovative endeavours in biotechnology. Our pioneering work in Gene Therapy provides us with a platform to research treatments for other debilitating neurological diseases. Our lead program has been de-risked by non-dilutive funding from LifeArc, and seed investment from Cure AP-4 and two private angel investors to date. Please contact us to discuss investment opportunities in BlackfinBio.